The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing

[#item_full_content]WILMINGTON, Del. & WHIPPANY, N.J.–(BUSINESS WIRE)– #API–The expansion addresses US injectable capacity shortages and growing demand for reliable domestic sterile manufacturing.